Jason Cross joined the Maxim Group as an associate in 2015 and become a partner of the firm in 2020. Jason is a Managing Director in the Merchant Capital Division, focused on sourcing and capital raising for emerging private and public biopharmaceutical drug development companies. Jason’s efforts have focused on a diverse investor network including ultra-high net worth individuals, institutions, and family offices. Since joining Maxim, Jason has participated in select financings in excess of $250 million across private and public capital markets. Prior to Maxim, Jason was a consultant for Capgemini Consulting in their Strategy & Transformation group with corporate clients in the pharmaceutical and consumer goods sector. Jason graduated from the Goizueta Business School at Emory University, and was President of the New York Chapter of Emory Alumni from 2017-2019.